-
AACR CEO Margaret Foti, PhD, MD (hc): Thank you for an extraordinary and impactful AACR Annual Meeting 2024
The 115th American Association for Cancer Research Annual Meeting featured a robust multidisciplinary scientific program united by the theme “Inspiring Science, Fueling Progress, Revolutionizing Care,” reflecting the AACR’s mission of preventing and curing all cancers.
-
Major themes and takeaways from Annual Meeting 2024 highlighted in final plenary session
Mikala Egeblad, PhD; Melissa A. Simon, MD, MPH; and Ryan B. Corcoran, MD, PhD, reviewed six days of sessions on basic cancer science and translational research; prevention, early detection, population sciences, and disparities research; and clinical research and clinical trials.
-
New Drugs on the Horizon sessions feature first disclosures of 12 new anticancer therapies
Three special sessions organized by the AACR Chemistry in Cancer Research (CICR) Working Group offered a first look at the structure, mechanism of action, and functional target modulation of novel cancer agents.
More News from #AACR24
-
Clinical trials plenary showcases targeted therapy advances
Jean Abraham, PhD, and other researchers presented findings on the efficacy and safety of PARP inhibitors and other targeted cancer treatments during a clinical trials plenary session.
-
Biomarkers of efficacy for emerging combination therapies explored in clinical trials plenary session
Mohummad Aminur Rahman, PhD, and other presenters discussed study data on biomarkers to identify potential patient subgroups for novel combination therapies.
-
Presidential Select Symposium looks at current, future directions in cancer immunotherapy research
James P. Allison, PhD, FAACR, and a panel of distinguished scientists shared insights into immune checkpoint blockades, cancer vaccines, CRISPR-modified CAR T cells, and CD4 T cells.
-
AACR-JCA joint session reviews advances in treatments and immunotherapies in gastroesophageal cancers
Tatsuhiro Shibata, MD, PhD, presented recent data on the driver gene landscape in a large dataset of gastric cancer patients, including those of East Asian and Eastern European ancestry, during a special joint session with the Japanese Cancer Association (JCA).
-
AACR-ASCO joint session discusses evolution in detection, treatment of minimal residual disease
Angela M. DeMichele, MD, examined strategies to therapeutically target dormant and reactivated MRD to prevent cancer recurrence during a special joint session with the American Society of Clinical Oncology (ASCO).
-
Radiation oncology researcher receives Charlotte Friend Lectureship award
Elizabeth Travis, PhD, was honored with the AACR-Women in Cancer Research Charlotte Friend Lectureship award in recognition of her trailblazing research on the effects of radiation on normal tissues, as well as for her devotion to championing women in science and medicine.